Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Protein Design Labs' human antihepatitis B antibody enters phase IIa

June 12, 1998

Maxamine plus IFN-alpha appears effective and safe in nonresponding HCV patients

June 11, 1998

First European clearance for Eisai's Pariet

June 11, 1998

Rebetron now available in the U.S.

June 9, 1998

Chinese herbal medicine reduces ALT levels in chronic hepatitis C

June 8, 1998

Zadaxin shows efficacy and safety in phase III trial for hepatitis B

June 8, 1998

Evaluation of rolipram in experimental animal models of colitis

June 5, 1998

FDA approves new combination therapy product for HCV

June 4, 1998

FDA advisory committee recommends approval of Avakine for Crohn's disease

May 29, 1998

Review study finds mesalamine most effective treatment for ulcerative colitis

May 29, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...